You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Harvard Business School
Moodys
Medtronic
Merck

Last Updated: July 16, 2020

DrugPatentWatch Database Preview

Hydroxychloroquine sulfate - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for hydroxychloroquine sulfate and what is the scope of freedom to operate?

Hydroxychloroquine sulfate is the generic ingredient in two branded drugs marketed by Accord Hlthcare, Alkaloida Zrt, Amneal Pharms Co, Appco, Havix, Hikma Pharms, Invatech, Ipca Labs Ltd, Laurus Labs Ltd, Lupin Ltd, Mylan, Sandoz, Teva Pharms, Watson Labs, Zydus Pharms Usa Inc, and Concordia, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for hydroxychloroquine sulfate. Twenty-seven suppliers are listed for this compound.

Drug Sales Revenue Trends for hydroxychloroquine sulfate

See drug sales revenues for hydroxychloroquine sulfate

Recent Clinical Trials for hydroxychloroquine sulfate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Texas Cardiac Arrhythmia Research FoundationN/A
Eli Lilly and CompanyPhase 2
Brian Wolpin, MD, MPHPhase 2

See all hydroxychloroquine sulfate clinical trials

Pharmacology for hydroxychloroquine sulfate
Medical Subject Heading (MeSH) Categories for hydroxychloroquine sulfate

US Patents and Regulatory Information for hydroxychloroquine sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alkaloida Zrt HYDROXYCHLOROQUINE SULFATE hydroxychloroquine sulfate TABLET;ORAL 201691-001 May 8, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Mylan HYDROXYCHLOROQUINE SULFATE hydroxychloroquine sulfate TABLET;ORAL 040274-001 May 29, 1998 AB RX No No   Start Trial   Start Trial   Start Trial
Invatech HYDROXYCHLOROQUINE SULFATE hydroxychloroquine sulfate TABLET;ORAL 040150-001 Jan 27, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
Havix HYDROXYCHLOROQUINE SULFATE hydroxychloroquine sulfate TABLET;ORAL 212902-001 May 14, 2020 AB RX No No   Start Trial   Start Trial   Start Trial
Hikma Pharms HYDROXYCHLOROQUINE SULFATE hydroxychloroquine sulfate TABLET;ORAL 040760-001 Aug 15, 2007 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Harvard Business School
Moodys
Medtronic
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.